| Literature DB >> 24288729 |
A B Vyshtakalyuk1, N G Nazarov, I V Zueva, A V Lantsova, O A Minnekhanova, D V Busygin, A G Porfiryev, V G Evtyugin, V S Reznik, V V Zobov.
Abstract
Xymedon (1-(β-oxyethyl)-4,6-dimethyl-1,2-dihydro-2-oxopyrimidine), a regeneratory and wound-healing drug, exhibited hepatoprotective activity in laboratory animals with experimental toxic hepatitis. Oral drug reduced the severity of toxic involvement of the liver induced by CCl4 and reduced animal mortality. Xymedon promoted recovery of the blood biochemical parameters characterizing the liver status.Entities:
Mesh：
Substances：
Year: 2013 PMID： 24288729 DOI： 10.1007/s10517-013-2215-0
Source DB: PubMed Journal: Bull Exp Biol Med ISSN： 0007-4888 Impact factor: 0.804